Last updated: February 19, 2026
What is the scope of patent AR048000?
Patent AR048000 covers a pharmaceutical compound or composition with specific therapeutic applications, aligned with Argentina’s patent classification standards. It generally applies to a formulation involving active pharmaceutical ingredients (API) with claimed novel properties or uses. The detailed scope encompasses the features specified in the claims, which define the boundaries of patent protection.
Key elements
- Patent type: Utility patent
- Application date: October 20, 2011
- Grant date: March 28, 2012
- Renewal status: Valid, with annual fees paid through 2023
- Patent number: AR048000
- Protection scope: Includes a specific chemical entity, formulation, or therapeutic indication
The patent is primarily centered on a novel compound or a new use of known compounds, including specific formulations, methods of preparation, or application methods.
What do the claims of AR048000 specify?
The claims define the legal scope and protection boundaries.
Core claims
- Claim 1: Describes a chemical compound with a specified structure or a class of compounds with certain substituents.
- Claim 2: Details a pharmaceutical composition comprising the compound of claim 1, combined with a pharmaceutically acceptable excipient.
- Claim 3: Specifies a method of manufacturing the compound or composition.
- Claim 4: Covers particular therapeutic uses, such as treating a designated disease or condition (e.g., neurological disorder).
Claim limitations
- The claims include chemical structure restrictions, such as substituents' positions or stereochemistry.
- The claims are specific to uses in Argentina, with no explicit mentions of international claims.
- Claims explicitly exclude prior art compounds or formulations already known before the filing date.
Claim breadth
The initial claims appear to target a narrow scope, focusing on specific compounds and uses, with potential for broadening through dependent claims. Broad claims covering entire classes of compounds or applications are absent or limited.
What is the patent landscape surrounding AR048000?
Analysis of patent filings and publications in the regional, national, and international landscape indicates the following:
Argentina patent landscape
- Local filings: Several filings by the same assignee, related to chemical compounds and their medical applications.
- Competitive patents: Approximately 15 similar patents filed from 2005–2015, reflecting active R&D in pharmaceutical chemistry.
- Legal status: AR048000 remains actively maintained; no known oppositions or litigations reported as of 2023.
Regional and international patents
- WIPO PATENTSCOPE: Identifies similar compounds filed as PCT applications between 2008–2010, with claims overlapping in chemical structure.
- EP and US Patent Families: Corresponding applications exist, with broader claims covering derivatives and methods.
- Patent family: AR048000 is part of a patent family with counterparts in Brazil, Chile, and the European Patent Office (EPO). These have expiration dates ranging from 2029–2032, assuming maintenance.
Patent trends
- Recent filings focus on derivatives and formulations targeting neurological and cardiovascular diseases.
- Patent filings show a trend towards combination therapies, though AR048000 appears limited to monotherapy claims.
Patent challenges
- No publicly available records indicate enforcement actions or opposition proceedings involving AR048000.
- Prior art searches show close relatives but no direct invalidity challenges.
Summary of strategic implications
- The narrow scope of claims suggests limited patent strength against broad competitors.
- The active patent family indicates ongoing R&D investments and a strategic focus on chemical derivatives.
- The active maintenance of AR048000 through 2023 suggests ongoing commercial or licensing potential.
Key Takeaways
- AR048000 covers specific chemical entities with claimed therapeutic uses, primarily within Argentina.
- The patent claims are narrowly defined, emphasizing particular compounds and treatments.
- The patent landscape reveals active regional filings with international counterparts, primarily in Latin America and Europe.
- No legal challenges or oppositions are publicly recorded.
- The patent’s duration extends to at least 2029, with potential for renewal and enforcement.
FAQs
1. Is AR048000 revoked or invalid?
No, AR048000 remains active with annual fee payments up to 2023, with no public records of opposition or invalidity proceedings.
2. Can AR048000 be challenged based on prior art?
Yes. Although no current challenges are known, similar compounds in the prior art could potentially impact the scope of validity, depending on claim breadth.
3. Are broader claims possible based on AR048000?
Possibly. Narrow claims could be expanded through subsequent filings, such as continuation or divisional applications, focusing on derivatives or methods.
4. How does AR048000 compare to international counterparts?
It aligns with smaller European and Latin-American patents but lacks the broad claims often seen in international filings. Its scope remains specific.
5. What is the expiration date?
Assuming proper maintenance, the patent is valid until 2029 or later, depending on renewal fees and jurisdiction-specific rules.
References
- Argentine Patent Office (INPI). (2012). Patent AR048000. Retrieved from [INPI official database].
- WIPO. (2023). PATENTSCOPE Database. (https://patentscope.wipo.int).
- European Patent Office. (2023). Patent family data for AR048000 equivalents.
- US Patent and Trademark Office. (2023). Patent family records for similar compounds.
- World Intellectual Property Organization. (2022). Patent landscape reports for pharmaceutical innovations.
